Advisor Group Holdings, Inc. Roivant Sciences Ltd. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,211 shares of ROIV stock, worth $33,554. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,211
Previous 3,081
4.22%
Holding current value
$33,554
Previous $35,000
5.71%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
334Shares Held
515MCall Options Held
1.13MPut Options Held
1.26M-
Qvt Financial LP New York, NY65.8MShares$688 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$649 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$500 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$461 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$370 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.36B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...